Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Incidental prostate cancer was found in 4.89% of patients undergoing surgery for benign prostatic hyperplasia.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Nanoparticles improve cancer treatment by reducing side effects and targeting cancer cells better.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Dutasteride may help shrink prostate cancer tumors.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Certain natural compounds called terpenes may help prevent prostate cancer.

Physical activity, height, and smoking affect prostate cancer risk.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Onions may help reduce cancer risk and obesity-related issues.

PCOS may increase the risk of certain cancers.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Serum triglyceride levels are not linked to prostate cancer risk.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Certain genetic markers may increase or decrease prostate cancer risk.

Certain genetic markers on the Y-chromosome may influence prostate cancer risk in Iraqi males.

Ayurvedic herbs may reduce side effects and improve effectiveness of cancer treatments.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Vitamin D may help regulate cholesterol and influence prostate cancer development.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.